Two phases of aging separated by the Smurf transition as a public path to death.
E Dambroise, L Monnier, L Ruisheng...
https://pubmed.ncbi.nlm.nih.gov/27002861/Actively Recruiting
Led by Direction Centrale du Service de Santé des Armées · Updated on 2026-08-31
126
Participants Needed
1
Research Sites
12 weeks
Total Duration
Researchers are investigating the relationship between increased intestinal permeability and survival chances in intensive care patients with single or multiple organ failure. Multivisceral failure syndrome MVFS is linked to a high mortality risk and systemic inflammation, with bacteremia often originating from digestive translocation, which is suspected but not yet proven in humans. This study aims to explore intestinal permeability in these patients, as current clinical practice does not systematically evaluate it. Participants will receive an oral dose of a food coloring dye based on their body weight to measure intestinal permeability. The study includes two groups patients with single organ failure and a SAPS2 score between 20 and 40, and patients with multi-organ failure and a SAPS2 score between 60 and 80. Feeding methods may be oral or via nasogastric tube, determined independently of study needs. Participants will be monitored for intestinal failure and survival up to 90 days after inclusion. The study will assess intestinal permeability in relation to organ failure severity. Consent and social security affiliation are required, and patients will be followed closely during their intensive care stay to collect relevant clinical data and outcomes. The trial is observational, with no experimental treatments administered.
CONDITIONS
Measurement of Intestinal Permeability in Intensive Care Patients With Single or Multiple Organ Failure
M
Michael RERA, PhD
R
Rachel HAUS, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Direction Centrale du Service de Santé des Armées
Lead Sponsor
Centre Borelli UMR 9010
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 screening visit
Duration - Up to 90 days post inclusion
Participants are observed and assessed for intestinal permeability and organ failure severity while receiving standard intensive care. Oral administration of a food coloring dye is used to measure intestinal permeability.
Regular assessments during intensive care stay
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
E Dambroise, L Monnier, L Ruisheng...
https://pubmed.ncbi.nlm.nih.gov/27002861/C E Harris, R D Griffiths, N Freestone...
https://pubmed.ncbi.nlm.nih.gov/1578045/Etienne Gayat, Alain Cariou, Nicolas Deye...
https://pubmed.ncbi.nlm.nih.gov/29347987/C J Doig, L R Sutherland, J D Sandham...
https://pubmed.ncbi.nlm.nih.gov/9700119/Stephanie A K Angarita, Sergio Duarte, Tara A Russell...
https://pubmed.ncbi.nlm.nih.gov/30502249/Direction Centrale du Service de Santé des Armées
Lead Sponsor
Centre Borelli UMR 9010
Collaborating Sponsor